| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-2952(96)00693-4 |
| P698 | PubMed publication ID | 8960070 |
| P2093 | author name string | T Tateishi | |
| F P Guengerich | |||
| A J Wood | |||
| P Soucek | |||
| Y Caraco | |||
| P2860 | cites work | Colchicine intoxication: Clinical pharmacology, risk factors, features, and management | Q36948153 |
| Alfred Burger award address. Bioactive alkaloids. 4. Results of recent investigations with colchicine and physostigmine | Q37949557 | ||
| Colchicine | Q39940883 | ||
| Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever | Q40808965 | ||
| Prolonged colchicine treatment in four patients with amyloidosis | Q40879753 | ||
| A prospective trial of colchicine for primary biliary cirrhosis | Q42659809 | ||
| Colchicine in the treatment of cirrhosis of the liver | Q49172380 | ||
| Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. | Q53943597 | ||
| Metabolic transformation of colchicine, II. The metabolism of colchicine by mammalian liver microsomes. | Q54475454 | ||
| Colc hicine treatment of Behqet's disease in children | Q61628572 | ||
| Long-term colchicine prophylaxis in familial Mediterranean fever | Q67692370 | ||
| Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene | Q68397000 | ||
| Separation of tubulin-binding and anti-inflammatory activity in colchicine analogs and congeners | Q69701365 | ||
| Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes | Q70458093 | ||
| Radioimmunoassay of colchicine with antisera exhibiting variable cross-reactivity | Q72010581 | ||
| Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment | Q72099809 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | (S)-(−)-colchicine | Q326224 |
| P304 | page(s) | 111-6 | |
| P577 | publication date | 1997-01-10 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation | |
| P478 | volume | 53 |
| Q50460964 | Biotransformation of colchicinoids into their corresponding 3-O-glucosyl derivatives by selected strains of Bacillus megaterium. |
| Q34152073 | Colchicine in clinical medicine. A guide for internists |
| Q37218927 | Colchicine-Induced Acute Neuromyopathy in a Patient Using Concomitant Fluconazole: Case Report and Literature Review |
| Q38554404 | Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori |
| Q40226708 | Colchicine-induced rhabdomyolysis following a concomitant use of clarithromycin in a haemodialysis patient with familial Mediterranean fever |
| Q53352157 | Colchicine: 1998 update. |
| Q44000042 | Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. |
| Q62633014 | Enhanced extraction of 3-demethylated colchicine from fermentation broth of Bacillus megaterium: Optimization of process parameters by statistical experimental design |
| Q44946713 | Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein |
| Q44499171 | Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats |
| Q36303746 | Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. |
| Q42850073 | Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management |
| Q79296519 | Risk factors for rhabdomyolysis with simvastatin and atorvastatin |
| Q46055776 | Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics |
| Q85938934 | Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease |
Search more.